Shanghai Menon Animal Nutrition Technology Co (301156) Fair Value & Analysis
Consumer Defensive · CN · Market cap 2.2B CNY
Fair value as of: Jun 24, 2026
Analysis
Shanghai Menon Animal Nutrition Technology Co (301156) currently trades at ¥12.00, while our model-based Fair Value estimate is ¥5.68 — implying the stock looks roughly 52.7% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research and development, production, and sale of feed additives and enzymatic protein feed raw materials in China. It offers food attractants, sweeteners, acidulants, plant extracts, sodium butyrate, butyric acid glyceride, emulsifiers, small peptides, etc. The company also provides fragrance, acidity regulator, flavoring agents, slow-release nitrogen sources, rumen-bypass amino acids, rumen-pass vitamins, and mineral elements, as well as enzymatic hydrolysis of vegetable protein. Its products are used in animal breeding fields such as pigs, ruminants, poultry, and aquatic products. The company also exports its products to Asia, Europe, North America, South America, Africa, Oceania, and internationally. Shanghai Menon Animal Nutrition Technology Co., Ltd. was founded in 1997 and is based in Shanghai, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Shanghai Menon Animal Nutrition Technology Co (301156) undervalued?
What is the fair value of 301156?
What is the quality score of 301156?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.